284 related articles for article (PubMed ID: 22552254)
41. High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.
Schulte C; Geisthoff U; Lux A; Kupka S; Zenner HP; Blin N; Pfister M
Hum Mutat; 2005 Jun; 25(6):595. PubMed ID: 15880681
[TBL] [Abstract][Full Text] [Related]
42. Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasia.
Duerig I; Pylaeva E; Ozel I; Wainwright S; Thiel I; Bordbari S; Domnich M; Siakaeva E; Lakomek A; Toppe F; Schleupner C; Geisthoff U; Lang S; Droege F; Jablonska J
J Leukoc Biol; 2023 Nov; 114(6):639-650. PubMed ID: 37555392
[TBL] [Abstract][Full Text] [Related]
43. Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function.
Mallet C; Lamribet K; Giraud S; Dupuis-Girod S; Feige JJ; Bailly S; Tillet E
Hum Mol Genet; 2015 Feb; 24(4):1142-54. PubMed ID: 25312062
[TBL] [Abstract][Full Text] [Related]
44. Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis.
McDonald J; Bayrak-Toydemir P; Pyeritz RE
Genet Med; 2011 Jul; 13(7):607-16. PubMed ID: 21546842
[TBL] [Abstract][Full Text] [Related]
45. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
Snodgrass RO; Chico TJA; Arthur HM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
[TBL] [Abstract][Full Text] [Related]
46. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
[TBL] [Abstract][Full Text] [Related]
47. Long non-coding RNA expression profiles in hereditary haemorrhagic telangiectasia.
Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
PLoS One; 2014; 9(3):e90272. PubMed ID: 24603890
[TBL] [Abstract][Full Text] [Related]
48. Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks.
Xu G; Barrios-Rodiles M; Jerkic M; Turinsky AL; Nadon R; Vera S; Voulgaraki D; Wrana JL; Toporsian M; Letarte M
Mol Cell Proteomics; 2014 Feb; 13(2):489-502. PubMed ID: 24319055
[TBL] [Abstract][Full Text] [Related]
49. Executive summary of the 11th HHT international scientific conference.
Arthur H; Geisthoff U; Gossage JR; Hughes CC; Lacombe P; Meek ME; Oh P; Roman BL; Trerotola SO; Velthuis S; Wooderchak-Donahue W
Angiogenesis; 2015 Oct; 18(4):511-24. PubMed ID: 26391603
[TBL] [Abstract][Full Text] [Related]
50. Hereditary hemorrhagic telangiectasia in Japanese patients.
Komiyama M; Ishiguro T; Yamada O; Morisaki H; Morisaki T
J Hum Genet; 2014 Jan; 59(1):37-41. PubMed ID: 24196379
[TBL] [Abstract][Full Text] [Related]
51. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
[TBL] [Abstract][Full Text] [Related]
52. Life expextancy of parents with Hereditary Haemorrhagic Telangiectasia.
de Gussem EM; Edwards CP; Hosman AE; Westermann CJ; Snijder RJ; Faughnan ME; Mager JJ
Orphanet J Rare Dis; 2016 Apr; 11():46. PubMed ID: 27102204
[TBL] [Abstract][Full Text] [Related]
53. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
Bossler AD; Richards J; George C; Godmilow L; Ganguly A
Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
[TBL] [Abstract][Full Text] [Related]
54. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
55. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
[TBL] [Abstract][Full Text] [Related]
56. Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site.
Plumitallo S; Ruiz-Llorente L; Langa C; Morini J; Babini G; Cappelletti D; Scelsi L; Greco A; Danesino C; Bernabeu C; Olivieri C
Gene; 2018 Mar; 647():85-92. PubMed ID: 29305977
[TBL] [Abstract][Full Text] [Related]
57. Endoplasmic reticulum quality control is involved in the mechanism of endoglin-mediated hereditary haemorrhagic telangiectasia.
Ali BR; Ben-Rebeh I; John A; Akawi NA; Milhem RM; Al-Shehhi NA; Al-Ameri MM; Al-Shamisi SA; Al-Gazali L
PLoS One; 2011; 6(10):e26206. PubMed ID: 22022569
[TBL] [Abstract][Full Text] [Related]
58. SMAD4 mutations found in unselected HHT patients.
Gallione CJ; Richards JA; Letteboer TG; Rushlow D; Prigoda NL; Leedom TP; Ganguly A; Castells A; Ploos van Amstel JK; Westermann CJ; Pyeritz RE; Marchuk DA
J Med Genet; 2006 Oct; 43(10):793-7. PubMed ID: 16613914
[TBL] [Abstract][Full Text] [Related]
59. Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.
Sugden WW; Siekmann AF
Curr Opin Hematol; 2018 May; 25(3):237-244. PubMed ID: 29438260
[TBL] [Abstract][Full Text] [Related]
60. Arteriovenous malformations in hereditary haemorrhagic telangiectasia: looking beyond ALK1-NOTCH interactions.
Peacock HM; Caolo V; Jones EA
Cardiovasc Res; 2016 Feb; 109(2):196-203. PubMed ID: 26645978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
